Navigation Links
Schering-Plough Reports Financial Results for 2007 Fourth Quarter, Full Year
Date:2/12/2008

lobal cholesterol joint venture net sales, which include VYTORIN and ZETIA, totaled $1.4 billion in the 2007 fourth quarter. Schering-Plough does not record sales of its cholesterol joint venture with Merck as the venture is accounted for under the equity method. Including an adjustment of an assumed 50 percent of the global cholesterol joint venture net sales, Schering- Plough's adjusted sales for the 2007 fourth quarter would have been $4.4 billion.

Overall, Schering-Plough shares in approximately 50 percent of the profits of the joint venture with Merck, although there are different profit-sharing arrangements for the cholesterol products in countries around the world. Schering-Plough records its share of the income from operations in "Equity income," which totaled $566 million in the 2007 fourth quarter, an increase of 40 percent versus $403 million in the fourth quarter of 2006. Schering-Plough noted that it incurs substantial costs such as selling, general and administrative costs that are not reflected in "Equity income" and are borne by its overall cost structure.

There is a separate co-marketing agreement with Bayer for ZETIA in Japan, where the product was launched in June 2007.

Sales of Global Pharmaceuticals for the 2007 fourth quarter totaled $3.0 billion. Included in the fourth quarter of 2007 are $409 million of net sales related to Organon, the OBS human health business.

Sales of REMICADE increased 35 percent to $455 million in the fourth quarter of 2007 due to continued market growth and expanded use across indications. REMICADE is a treatment for inflammatory diseases that Schering- Plough markets in countries outside the United States (except in Japan and certain other Asian markets) for rheumatoid arthritis, early rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, Crohn's disease, pediatric Crohn's disease and ulcerative colitis.

Global sales of NASONEX, an inhaled nasal cortico
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Schering-Plough and OraSure Technologies Sign International Collaboration for Rapid Point-of-Care Oral Hepatitis C Test
2. Schering-Plough Announces Organizational Changes at Schering-Plough Research Institute
3. FDA Grants Priority Review for Schering-Ploughs Peginterferon Alfa-2b for the Adjuvant Treatment of Patients With Stage III Melanoma
4. Schering-Plough Announces Sugammadex New Drug Application Filed in Japan
5. Schering-Plough Announces New Drug Application for Sugammadex Assigned Priority Review Status by U.S. FDA
6. Schering-Plough to Webcast Presentation at Morgan Stanley Pharmaceutical CEOs Unplugged Conference
7. Schering-Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter, Full-Year Financial Result
8. Schering-Plough Wins Three of Scrips Top Pharma Industry Awards
9. Schering-Plough Completes Acquisition of Organon BioSciences
10. Schering-Plough Receives Approval from European Commission for Planned Acquisition of Organon BioSciences N.V.
11. Schering-Plough to Webcast Presentation at Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., , COPENHAGEN, Nov. 19 Danish...bicon cellulosic ethanol plant in Kalundborg, Denm...e of the world,s first and largest 2nd generation ...cellerase enzymes are used in the plant,s innovati... a Division of Danisco, was the first to market wi...
(Date:11/19/2009)..., , BLAUVELT, N.Y., Nov. 19 D...t germ extract, responds to a press release issued...e Hungarian company for making false and self-serv...BioSciences. ,, Dr. Hidvegi stated from his of...claim that research on Avemar does not apply to Av...
(Date:11/19/2009)..., , NEW YORK, Nov. 19 /PRNewswire-FirstCall/ ...ay that it has sent the following letter to its sh...on October 30, 2009, of China Biopharmaceuticals H...ical company based in the People,s Republic of Chi...erest in Suzhou Eyre Pharmaceutical Co. Ltd., CHBP...
(Date:11/19/2009)..., , MALVERN, Pa. and WALTHAM, Mass., Nov....MR) and Decision Resources find that the leading d...nia in Europe is broad-spectrum activity against g...he variety of organisms that can cause nosocomial ...t they look primarily for agents that provide appr...
Breaking Biology Technology:DONG Energy and Inbicon Inaugurate One of the World's Largest Demo Plants for 2nd Generation Biofuel 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 2NeoStem Outlines to Shareholders Near-term and Long-term Business Strategies Following Acquisition of Chinese Pharmaceutical Company 3Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3
...oration (OTC Bulletin Board: CCYG) announced today...U.S. patent (U.S. Patent No. 7,282,222) for its,un...and direct stem cells,to target organs in the body... licensed to CellCyte,from the US Department of Ve...l enabling therapeutic products designed to allow ...
...c. (Amex: PTN ) announced today financial results...alatin reported a net loss of $247,000, or $0.00,p...September 30, 2007,compared to a net loss of $8.4 ...or the same period in 2006. Total revenues for the...n, compared to $4.9 million for the same,period in...
...8:00 a.m. PST -, SAN DIEGO, Nov. 8 Halozyme Ther...al company developing and commercializing,products... financial,results for the three and nine months e...ilities in navigating the complexities of the,extr...rtunities to build,shareholder value," said Jonath...
Other Biology Technology:Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington 2Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington 3Patent on Technology for the Delivery of Stem Cells to the Human Heart Issued to CellCyte Genetics Corp. of Washington 4Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 2Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 3Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 4Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 5Palatin Technologies, Inc. Reports Fiscal Year 2008 First Quarter Results; Teleconference and Webcast to be Held on November 9, 2007 6Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 2Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 3Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 4Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 5Halozyme Therapeutics Reports 2007 Third Quarter Financial Results 6
(Date:11/19/2009)...year, multi-institutional effort co-led by three C...minated today in publication of a landmark series ...precedented detail the DNA sequence of maize ( Zea...by North American consumers, is one of the world,s...ultural crop grown in the United States, represent...
(Date:11/19/2009)...PRNewswire-FirstCall/ -- BIO-key International, In...s public safety and finger-based biometric identif...eholder Meeting held today was adjourned without a...sent. ,, (Logo: http://www.newscom.com/cgi-bin...ve 99.3% of the 35 million votes cast voted in fav...
(Date:11/19/2009)... Sustainable farming, initially adopted to preserv...ay a role in maintaining a healthy climate, accord...ak Ridge and Los Alamos national laboratories. , ...potential of the earth,s soils to sequester carbon...ces could greatly reduce U.S. carbon emissions by ...
Breaking Biology News(10 mins):Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 2Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 3Reference genome of maize, most important US crop, is published by team co-led by CSHL scientists 4BIO-key(R) Provides Update to Special Shareholder Meeting 2BIO-key(R) Provides Update to Special Shareholder Meeting 3ORNL, Los Alamos pioneer new approach to assist scientists, farmers 2ORNL, Los Alamos pioneer new approach to assist scientists, farmers 3Los Angeles Surgeon Dr Rezaian Pioneers Cutting Edge Laser Back Surgery 28laserbacksurgery com 29 52837 1Los Angeles Surgeon Dr Rezaian Pioneers Cutting Edge Laser Back Surgery 28laserbacksurgery com 29 52837 2Tennessee Drug Card Has Saved Residents Over 247 3 Million 52835 1Tennessee Drug Card Has Saved Residents Over 247 3 Million 52835 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 1Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 2Human Genome Sciences Announces Proposed Public Offering of Common Stock 13215 3
...e engineered yeast that can improve the speed and ...to making biofuels a significant part of the U.S. ... to improve gasoline combustibility, ethanol is of...oil-driven energy crisis. But there are significan... ethanol levels are toxic to the yeast that fermen...
...tion of jaw movement while words are spoken, resea...rtance of non-auditory sensory cues in the brain,s...azzad Nasir and David Ostry of McGill University a... Current Biology, published by Cell Press. , When...s is dependent not only on auditory feedback signa...
...r Institute have identified a novel biomarker for ...he marker may play when the tumor spreads or comes...levated in the cerebrospinal fluid of patients wit...igration," is published in the November issue of C...ein known as "soluble attractin," is normally abse...
Other Biology News:Engineered yeast speeds ethanol production 2Sensory feedback during speech: The brain attunes to more than just sound 2Newly identified biomarker detects and regulates spread of brain tumors 2
Mastercycler gradient from Eppendorf North America
Rnase-free Ribonuclease Inhibitor from Chimerx
...ion interface. All the functionality of the micro1...d memory and more available channels of waveform i...tion for programmable front-end gain. Can be expan... from 4 to 8 waveform outputs at 16 bit resolution...
...igned to provide a thin film-like barrier when a c...is barrier creates the proper surface tension to h... the slide. PAP Pen contains a special formulatio...an be removed, if desired, by xylene after the sta...
Biology Products: